“Opioids are opioids…they can lead to long-term usage regardless of their FDA class. We really need to be good stewards for our patients,” says Sarah F. Faris, MD.
In this episode, Urology Times® Managing Editor Ben Saylor spoke with Sarah F. Faris, MD. She discusses the recent Urology study, “Persistent Opioid Usage After Urologic Intervention and the Impact of Tramadol,” and how clinicians need to take precaution when prescribing opioids for postoperative care. Faris is an associate professor of surgery at the University of Chicago, Illinois.